Jade Biosciences, Inc. Common Stock (JBIO)

NASDAQ: JBIO • USD
15.49 USD
-0.05 (-0.35%)
AT CLOSE (11:59 AM EDT)
15.47
-0.03 (-0.16%)
POST MARKET (AS OF 06:44 PM EDT)
🔴Market: CLOSED
Open?$15.52
High?$16.19
Low?$15.22
Prev. Close?$15.49
Volume?402.9K
Avg. Volume?485.8K
VWAP?$15.66
Rel. Volume?0.83x
Bid / Ask
Bid?$13.95 × 2.4K
Ask?$16.50 × 300
Spread?$2.55
Midpoint?$15.23
Valuation & Ratios
Market Cap?763.9M
Shares Out?49.3M
Float?37.6M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?4.26
EPS?-$1.05
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.01Strong
Quick Ratio?9.01Strong
Cash Ratio?2.24Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A▾
P/B?
4.26FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-11.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-28.8%WEAK▾
ROA?
-25.5%WEAK▾
Cash Flow & Enterprise
FCF?$-72280000
Enterprise Value?$713.8M
Related Companies
Loading...
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Employees
55
Market Cap
763.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.jadebiosciences.com
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
MarketsMoversWatchlist